Safety and Efficacy Study of Dysport RU and Glabellar Lines
NCT01333397
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
176
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
Botulinum toxin type A
BIOLOGICAL:
Botulinum toxin type A
DRUG:
Placebo
Sponsor
Ipsen